Stage 6 of 7 · STRAW +1c

Postmenopause, years 2–10: the mentor decade

Two to ten years past your final period, the symptom storm settles — hot flushes fade for most women, the 3am waking eases — and the question quietly changes from "what's happening to me?" to "what am I protecting for the next twenty years?" This is STRAW+10 stage +1c, often called the mentor decade. Your hormones have found a low, steady baseline; the work that remains is long-term and mostly silent — bone, heart, and the genitourinary tissues — plus the recognised question of whether HRT started later still makes sense.

Last verified: 10 July 2026 · staging per STRAW+10 · Malta facts checked against primary sources · re-verified quarterly

What stage am I in, 2 to 10 years after my last period?

You are in mid-postmenopause — STRAW+10 stage +1c, roughly the second to tenth year past your final menstrual period (FMP), usually somewhere between ages 50 and 60. With the average final period around 51, most women are in their mid-to-late fifties here. The volatility of the transition is years behind you now, and your oestradiol sits at a settled low baseline your body has adjusted to.

The shift in this stage is one of purpose, not just symptoms. Early postmenopause was the sorting year — what stays, what goes, what to lock in. The mentor decade is maintenance ground: holding what you have, on a calendar, rather than reacting to a storm. In the Maltese tradition, these are the years long handed to the nanna and the zia — the women who are asked, not the ones who ask permission.

What changes in this stage?

The loud symptoms mostly settle. Hot flushes and night sweats have faded for most women by now; for a smaller number they still flicker, usually milder than before. Some women notice desire returning once the worst of the upheaval is behind them. The relief is real — but it is not the same as the health work being finished.

The silent changes are what matter now, because this is where the compound interest of the next twenty years is paid out, for or against you:

• Bone. The fastest bone loss was the first years after your FMP; by now it is slowing, but it keeps adding up quietly — until, sometimes, a fracture. A bone-density baseline is the point of these years.
• Heart. The cardiovascular protection oestrogen gave for decades has lifted, so cholesterol, blood pressure and blood sugar can drift. This is why they move onto a calendar and get tracked, not felt.
• Genitourinary syndrome (GSM). Vaginal dryness and recurrent urinary infections continue, and unlike hot flushes they worsen rather than fade when left untreated — see GSM in Malta.

None of this is your character or a failure of willpower. It is the same hormonal shift, now steady rather than swinging. And "natural" here has too often meant permission to disappear — to stop minding your own skin, sleep and bones. Skin, bone, heart and brain are health, not vanity; tending them is how the mentor-decade standing is built, not spent.

Do I still need to think about HRT? (The late-window question)

This is the decision that defines the stage, and it deserves to be named plainly rather than answered glibly. The evidence points to a timing window: the balance of benefit over risk is most favourable when systemic HRT is started before age 60, or within ten years of the final period. Inside that window, benefit tends to outweigh risk, with likely protection for bone and heart. Started well outside it — especially in older women whose arteries have already stiffened — the balance shifts, and the risks can start to outweigh the benefits.

The mentor decade straddles the edge of that window. If you are a few years past your FMP and under 60, you may still be inside it; further out, late initiation becomes a recognised consideration weighed case by case — against your history, your bone and heart picture, and your reasons for wanting it — not a protocol anyone applies automatically. This is a genuinely individual conversation for a doctor who knows you, which is exactly why a page like this stops at naming the question.

What does this stage look like in Malta?

Quieter than it should. As of June 2026, HRT for menopause is not publicly funded in Malta — it is bought privately — and there is no dedicated public menopause clinic at Mater Dei Hospital or Gozo General; menopause sits inside general gynaecology, reached by GP referral. The Maltese menopause conversation also tends to thin out after the transition itself, so this later stretch is where content and follow-up go quietest — and there is no published peer-reviewed Maltese cohort tracking what actually happens to women in these years. Continuing care here usually means asking for it: a bone-density (DEXA) baseline, a cardiovascular check, and treatment for genitourinary symptoms that will not resolve on their own.

For the money side of a bone and cardiovascular baseline, see blood tests in Malta and what menopause care costs — labs and clinics in Malta quote prices at booking rather than publishing them.